Raybow USA

Raybow USA, founded in 2018 and headquartered in Brevard, North Carolina, is a specialized chemical CDMO and a key North American subsidiary of the global Jiuzhou Pharma group. The company leverages over 25 years of operational experience in North Carolina to offer integrated services from research and development through to commercial-scale cGMP production of APIs and specialty chemicals. Its value proposition centers on a collaborative approach, regulatory compliance, and seamless access to its parent company's international network of facilities and chemists in North America, Europe, and China. Raybow positions itself as a partner to accelerate time-to-market for innovative products across the pharmaceutical and chemical industries.

Integrated chemical CDMO platform offering custom synthesis, process development, analytical services, and cGMP/non-GMP manufacturing for small molecules, specialty chemicals, and polymers. Leverages synthetic chemistry expertise, project management, and a global parent company network for scale.

Raybow operates in the highly competitive CDMO sector, competing with large public players (e.g., Lonza, Catalent, Thermo Fisher Scientific) and numerous specialized private firms. Its differentiation lies in its mid-size flexibility, deep chemical expertise, and the strategic advantage of being a U.S.-based gateway to Jiuzhou Pharma's global manufacturing network in China and Europe.